Sphygmomanometer Market - By Product (Digital Sphygmomanometer [Wrist], Aneroid Sphygmomanometer, Mercury Sphygmomanometer), Operation (Manual, Automatic, Semi-automatic), Configuration (Portable, Desk Mounted, Wall Mounted), End Use & Forecast, 2024 – 2032

Sphygmomanometer Market Size

Sphygmomanometer Market size was valued at USD 3.4 billion in 2023 and is expected to exhibit growth at a CAGR of 8.5% from 2024 to 2032. The strong market growth is driven by the rising prevalence of cardiac conditions, advancements in technology, and the continuous introduction of innovative products.

The market growth is further attributed to growing awareness of hypertension and other cardiovascular diseases. Rising health consciousness and preventive healthcare initiatives are driving individuals and healthcare facilities to adopt more accurate and reliable blood pressure monitoring devices. Additionally, the growing geriatric population, who are more susceptible to blood pressure-related health issues, is contributing to the surging demand for sphygmomanometers.
 

Technological advancements are playing a crucial role in the market's expansion. Innovations in sphygmomanometer technology, including digital and automated devices, offer greater accuracy and user convenience. For example, in July 2023, Smart Meter launched a new cellular-connected, multi-cuff blood pressure monitor designed specifically for chronic care management. The integration of smart features and connectivity options is resonating with both consumers and healthcare professionals, driving further market growth. The enhanced functionality of vital sign monitoring devices and the ease of use of these devices are making them increasingly appealing to a broader audience.
 

A sphygmomanometer is a medical instrument used to measure blood pressure, a key indicator of cardiovascular health. It typically comprises an inflatable cuff, a pressure gauge, and, in some cases, a stethoscope. The cuff is wrapped around the upper arm and inflated to temporarily stop blood flow. As the cuff deflates, the gauge measures the pressure of the blood flow through the arteries. Sphygmomanometers can be manual, requiring manual inflation and auscultation, or digital providing automated readings and often integrating with electronic health systems for data management and analysis.
 

Sphygmomanometer Market Trends

The market is evolving with several key trends shaping its trajectory. The shift towards digital sphygmomanometers is a prominent trend, driven by the need for more precise and user-friendly devices. Digital sphygmomanometers offer automatic readings and eliminate the need for manual interpretation, catering to a growing demand for convenience and accuracy in both home and clinical settings.
 

• Additionally, the rise of telemedicine and remote patient monitoring is fueling the adoption of connected sphygmomanometers that sync with health apps and electronic health records, providing real-time data to healthcare providers.
   
• Another significant trend is the development of portable and compact sphygmomanometers. As people increasingly prioritize health and fitness, the demand for devices that can be used on the go is rising. Portable sphygmomanometers meet this need by offering convenience and flexibility, allowing users to monitor their blood pressure anytime, anywhere. Additionally, advancements in wearable technology are leading to the integration of sphygmomanometers into wearable devices, enabling continuous blood pressure monitoring and enhancing overall health management.
   

Sphygmomanometer Market Analysis

Based on product, the market is classified into digital sphygmomanometer, aneroid sphygmomanometer, and mercury sphygmomanometer. The digital sphygmomanometer segment generated the highest revenue of USD 2 billion in 2023.
 

• Digital sphygmomanometers hold a significant share of the market due to their advanced features and user-friendly design. Unlike traditional manual devices, digital sphygmomanometers provide automatic readings, reducing the potential for human error and ensuring more accurate results. The ease of use and convenience associated with digital sphygmomanometers are appealing to both consumers and healthcare professionals.
   
• In addition, the growth of the digital sphygmomanometer segment is also driven by technological advancements. Modern digital sphygmomanometers are equipped with sophisticated sensors and algorithms that improve measurement accuracy and reliability. Additionally, the integration of digital sphygmomanometers with mobile apps and electronic health records allows for seamless data management and monitoring. This connectivity is particularly valuable for patients with chronic conditions who require regular blood pressure monitoring, contributing to the widespread adoption of digital sphygmomanometers in both home and clinical settings.
   

Based on operations, the sphygmomanometer market is categorized into manual, automatic, and semi-automatic. The manual segment generated the highest revenue of USD 1.4 billion in 2023.
 

• The manual operation provides a high level of precision, making these devices a preferred choice for clinical environments where accurate measurements are critical. Manual sphygmomanometers are also known for their durability and longevity, which adds to their substantial share in the market.
   
• Furthermore, manual sphygmomanometers are often more affordable compared to their digital counterparts. This cost-effectiveness makes them accessible to a broader range of healthcare facilities, particularly in developing regions where budget constraints are a concern. Despite the growing popularity of digital devices, the simplicity, reliability, and lower cost of manual sphygmomanometers ensure their continued dominance in the market, especially in settings where budget limitations or specific clinical needs are a consideration.
   

Based on configuration, the sphygmomanometer market is categorized into portable, desk mounted, floor standing, and wall mounted. The portable segment generated the highest revenue of USD 2.5 billion in 2023.
 

• The portable sphygmomanometer segment is experiencing substantial growth due to the increasing demand for convenient and flexible blood pressure monitoring solutions. Portable sphygmomanometers offer the advantage of being easily carried and used in various settings, including home, work, and travel. The compact design and ease of use of portable sphygmomanometers cater to the growing trend of personal health management and preventive care.
   
• Further, modern portable devices often feature advanced sensors and digital displays, providing accurate readings in a compact form factor. The integration of connectivity features, such as Bluetooth, allows users to sync their readings with health apps and electronic health records, facilitating better health management and tracking.
   

Based on end-use, the sphygmomanometer market is segmented into hospital, homecare, ambulatory surgical centres, and other end-users. The hospital segment dominated the market in 2023 and is anticipated to reach USD 3.1 billion by the end of the forecast period.
 

• Hospitals require devices that offer precise measurements and can withstand frequent use. Both digital and manual sphygmomanometers are employed in hospitals, with digital devices being increasingly adopted for their ease of use and integration with electronic health systems. The critical role of blood pressure monitoring in patient care ensures that hospitals remain a major market for sphygmomanometers.
   
• The growing focus on patient safety and quality of care in hospitals is also contributing to the high demand for advanced sphygmomanometers. Hospitals are investing in state-of-the-art devices that offer accurate and consistent readings, which are crucial for effective treatment and monitoring of patients. Additionally, the rise of digital sphygmomanometers with features such as automated readings and data storage aligns with the healthcare industry's move towards digitalization and improved patient outcomes, further reinforcing the dominant market position of hospitals as a key end-use segment.
   

North America sphygmomanometer market accounted for USD 640.7 million market revenue in 2023 and is anticipated to grow at a CAGR of 6.1% between 2024 – 2032 period.
 

• The North America market growth is attributed to the growing prevalence of hypertension and related cardiovascular conditions. With an increasing number of individuals being diagnosed with high blood pressure, there is a greater need for reliable and accurate blood pressure monitoring devices. The advanced healthcare infrastructure in North America supports this demand by providing access to both traditional and cutting-edge sphygmomanometers, including digital models with advanced features.
   
• Moreover, the region's emphasis on preventive healthcare and patient self-management has led to a rise in home health monitoring. The availability of user-friendly sphygmomanometers that integrate with digital health apps and electronic health records aligns with the trend of personal health management, further driving adoption across both home and clinical settings.
   

U.S. sphygmomanometer market accounted for USD 590.8 million market revenue in 2023 and is estimated to hold a substantial share between 2024 – 2032 period.
 

• In the U.S., the adoption of sphygmomanometers is on the rise due to the high incidence of hypertension and a strong focus on cardiovascular health management. The country’s health system emphasizes early detection and continuous monitoring of blood pressure, leading to increased use of sphygmomanometers in both clinical and home settings. Innovative digital sphygmomanometers, which offer automated readings and connectivity features, appeal to both consumers and healthcare providers.
   
• Additionally, the rise of telemedicine and remote patient monitoring in the U.S. has further boosted sphygmomanometer adoption. Devices that connect to health apps and provide real-time data are increasingly used to manage chronic conditions and facilitate virtual consultations, enhancing the convenience and effectiveness of blood pressure monitoring.
   

UK sphygmomanometer market is projected to grow remarkably in the coming years.
 

• In the UK, the adoption of sphygmomanometers is growing as part of the National Health Service (NHS) initiatives to improve cardiovascular health. The NHS promotes regular blood pressure monitoring as a preventive measure, leading to increased use of sphygmomanometers in both clinical and home environments. Digital sphygmomanometers with automatic readings and data storage are becoming more prevalent, supporting the NHS's goal of enhancing patient care and early detection.
   
• Furthermore, the rise of home health monitoring and personal health management in the UK is driving the demand for sphygmomanometers. As individuals become more proactive about their health, the availability of advanced, easy-to-use devices that integrate with health management systems is contributing to the increased adoption of these devices across the country.
   

Japan holds a dominant position in the Asia Pacific sphygmomanometer market.
 

• In Japan, the adoption of sphygmomanometers is rising due to the aging population and the associated increase in hypertension and cardiovascular diseases. The country’s focus on preventive healthcare and early diagnosis drives the demand for accurate and reliable blood pressure monitoring. Digital sphygmomanometers with advanced features, such as automatic readings and data connectivity, are increasingly used to manage chronic conditions effectively.
   
• Additionally, Japan’s emphasis on technological innovation has led to the development of compact and portable sphygmomanometers. These devices cater to the needs of a health-conscious population and fit well with the country’s trend towards integrating health monitoring technologies into daily life, further boosting the adoption of sphygmomanometers.
   

Sphygmomanometer Market Share

Key players in the market are continually investing in research and development to enhance product features and performance. Major companies are focusing on developing advanced digital sphygmomanometers with smart technologies, such as Bluetooth connectivity and integration with mobile health applications. Industry leaders are also expanding their product portfolios and exploring new market opportunities to stay competitive and meet the evolving needs of healthcare providers and consumers.
 

Sphygmomanometer Market Companies

Prominent players operating in the sphygmomanometer industry include:

• A&D Company, Limited
• ACCOSON
• American Diagnostic Corporation
• Beurer GmbH
• Bosch + Sohn GmbH & Co. KG
• BPL Medical Technologies Pvt. Ltd.
• GE Healthcare
• Little Doctor International (S) Pte. Ltd.
• Microlife Corporation
• Omron Healthcare, Inc.
• Prestige Medical
• Rudolf Riester GmbH
• Rossmax International Ltd.
• Spengler SAS
• SunTech Medical, Inc.
   

Sphygmomanometer Industry News:

• In June 2023, a group of researchers at UCSD Jacobs School of Engineering developed pocket blood pressure monitoring devices that can be connected to smartphones for real-time data.
   

The sphygmomanometer market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and Units from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Digital sphygmomanometer
  • Arm electronic sphygmomanometer
  • Wrist electronic sphygmomanometer
• Aneroid sphygmomanometer
• Mercury sphygmomanometer

Market, By Operations

• Manual
• Automatic
• Semi-automatic

Market, By Configuration

• Portable
• Desk mounted
• Floor standing
• Wall mounted

Market, By End-use

• Hospitals
• Homecare
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa